Pharmaceuticals

Genomic Cancer Panel And Profiling Market 2026–2030: Emerging Trends and Forecast Opportunities

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genomic cancer panel and profiling market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Genomic Cancer Panel And Profiling Market between 2026 and 2030?

The genomic cancer panel and profiling market size has shown substantial expansion in recent years. It is anticipated to grow from $10.28 billion in 2025 to $11.17 billion in 2026, at a compound annual growth rate (CAGR) of 8.7%. This growth observed in the past can be ascribed to factors such as the rise in cancer prevalence, advancements in sequencing technologies, the expansion of oncology diagnostics, increased funding dedicated to genomic research, and the increasing adoption of precision medicine.

The genomic cancer panel and profiling market is forecast to undergo significant expansion in the upcoming years. Its valuation is expected to climb to $15.45 billion by 2030, demonstrating a compound annual growth rate of 8.4%. This projected growth during the forecast period is primarily driven by the widening application of companion diagnostics, an increase in liquid biopsy adoption, the incorporation of AI into genomic analysis, expanding oncology screening programs, and the creation of cost-effective sequencing platforms. Noteworthy trends anticipated in this period encompass a rise in the use of multi-gene cancer panels, increasing reliance on next-generation sequencing, the broadened availability of liquid biopsy testing, a growing need for personalized oncology treatments, and the integration of genomic data into clinical decision-making.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Genomic Cancer Panel And Profiling Market?

The escalating incidence of cancer is projected to propel the expansion of the genomic cancer panel and profiling market in the future. Cancer is a condition marked by the uncontrolled multiplication and spread of abnormal cells within the body. The uptick in cancer cases stems from an aging population, which heightens the probability of cancer development as life expectancy continues to rise. Genomic cancer panels and profiling contribute to oncology care by identifying genetic mutations and biomarkers, enabling personalized treatment plans, and improving early detection and monitoring. For instance, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2022, approximately 20 million new cancer cases occurred globally, resulting in 9.7 million deaths; primarily driven by population growth, the worldwide cancer burden is anticipated to reach 35 million cases by 2050. Therefore, the increasing cancer incidence will fuel the growth of the genomic cancer panel and profiling market.

What Segments Are Included Within The Genomic Cancer Panel And Profiling Market?

The genomic cancer panel and profiling market covered in this report is segmented –

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies

3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel

4) By Application: Clinical, Research

5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues

2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

How Are New Market Trends Shaping The Landscape Of The Genomic Cancer Panel And Profiling Market?

Leading companies active in the genomic cancer panel and profiling market are emphasizing technological advancements, such as next-generation sequencing devices, to enhance the accuracy, speed, and overall scope of cancer diagnostics and to enable more tailored treatment decisions. Next-generation sequencers are sophisticated DNA sequencing technologies that facilitate rapid, high-throughput analysis of genetic material to identify mutations, variations, and other genomic characteristics. For instance, in April 2025, QIAGEN N.V., a biotechnology firm located in the Netherlands, introduced QIAseq panels specifically designed for next-generation sequencers, allowing for comprehensive genomic profiling by analyzing over 700 genes. These panels are intended for both research and clinical applications, with the aim of improving cancer diagnostics and treatment strategies.

Who Are The Core Companies Influencing Trends In The Genomic Cancer Panel And Profiling Market?

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genomic-cancer-panel-and-profiling-global-market-report

Which Regions Are Projected To Dominate The Genomic Cancer Panel And Profiling Market In The Coming Years?

North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genomic Cancer Panel And Profiling Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp

Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2026, By The Business Research Company

Cancer Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Cancer Tumor Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795